AngioDynamics, Inc. (ANGO) vs Anbio Biotechnology (NNNN)

AngioDynamics, Inc. and Anbio Biotechnology are both Medical Instruments & Supplies companies. AngioDynamics, Inc. and Anbio Biotechnology are of similar size ($487.0M and $474.8M). Across the 8 metrics below, Anbio Biotechnology leads on 7 and AngioDynamics, Inc. on 1.

Valuation

Metric ANGO NNNN Medical Instruments & Supplies median
P/E n/m — 33.75
P/S 1.45 — 2.52
P/B 2.88 n/m 2.48
Price to free cash flow n/m n/m 25.19
EV/EBITDA n/m n/m 14.62
EV/Sales 1.52 n/m 2.88
Earnings yield (6.92%) — (2.67%)
Free cash flow yield (0.50%) 0.00% 0.09%

Profitability

Metric ANGO NNNN Medical Instruments & Supplies median
Gross margin 55.65% — 54.29%
Operating margin (11.24%) — 1.07%
Net margin (10.12%) — (1.61%)
Free cash flow margin 0.44% 0.00% 1.08%
Return on equity (19.21%) 0.00% (1.32%)
Return on assets (12.98%) 0.00% 0.00%
Return on invested capital (17.58%) 0.00% 0.00%

Growth

Metric ANGO NNNN Medical Instruments & Supplies median
Revenue growth (TTM) 8.20% — 8.85%
EPS growth (last fiscal year) (6.02%) 150.00% 8.65%
Revenue growth, 5-year CAGR 1.93% — 9.17%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ANGO NNNN Medical Instruments & Supplies median
Debt to equity 0.00 0.00 0.10
Current ratio 2.40 344.45 2.48
Net debt to EBITDA 3.17 (2.06) 0.89

Dividend

Metric ANGO NNNN Medical Instruments & Supplies median
Dividend yield — — 1.11%
Payout ratio — — 0.27

Size

Metric ANGO NNNN Medical Instruments & Supplies median
Market cap 486.99m 474.84m 619.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack